Co-Trimoxazole
Cotrimoxazole is a combination of trimethoprim and sulfamethoxazole. Cotrimoxazole is used to treat a variety of bacterial infections such as uncomplicated UTIs, respiratory tract infections, and gastrointestinal infections.
Primary Characteristics
It is of Synthetic origin and belongs to Sulphonamide, Trimethoprim.
It is classified in Antibiotic, Sulphonamide Derivative pharmacological group.
Molecular Weight: 253.21 · pKa: 5.6 · Solubility in Water: very slight · Solubility in Alcohol: 1 in 50 · Non-proprietary name: Co-Trimoxazole.

Pharmacokinetics
Absorption: Co-Trimoxazole has an oral bioavailability is 90% (±5%).
Distribution: Co-Trimoxazole has a volume of distribution is 12-18, 70-100 litre. plasma protein binding is 42-66%.
Elimination: it is metabolised via 60-70%, plasma half-life is 9-10 hr, renal excretion is 70%.
Advertisement
Indications
Co-Trimoxazole is primarily indicated in conditions like Acute exacerbation of chronic bronchitis, Anorectal infections, Brucellosis, Chancroid, Cholera, Chronic bronchitis, Diarrhoea, Genitourinary tract infections, GI infections, Gonorrhoea, Metastatic germ cell cancer, Oliguria due to renal failure, Oliguria due to renal failure, Oropharangeal candidiasis, Orophyrangeal infections, Osteomyelitis, Otitis media, Pneumocystis carinii infections, Pneumonia, Respiratory tract infections, Septicaemia, Skin infections, Squamous cell carcinoma, Travelers diarrhoea, Uncomplicated UTIs.
Co-Trimoxazole is also indicated for secondary conditions like Cancer, Infections, Oliguria, Prostatic cancer, Salmonellosis.
Contraindications
Co-Trimoxazole is contraindicated in conditions like Impaired renal function, Haematological disorders, Liver parenchymal damage, Hypersensitivity.
Dosage
Co-Trimoxazole's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 2.88 mg | 2.88 mg | Every 12h | PO | 2 divided doses in serve infection |
| 960 mg | 960 mg | Every 12h | PO | |
| Paediatric Dosage (20kg) | ||||
| 24 mg/kg | 24 mg/kg | Every 12h | Oral | - |
| 24 mg/kg | 24 mg/kg | Every 12h | Slow IV | - |
| Neonatal Dosage (3kg) | ||||
| 22.5 mg/kg | 22.5 mg/kg | Every 12h | oral | |
| 22.5 mg/kg | 22.5 mg/kg | Every 12h | Slow intravenous | |
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Co-Trimoxazole in overdosage may give rise to further complications which include Neutropenia , Hemolytic anemia, Megaloblastic anemia, Aplastic anemia , Hemolytic anemia , Stevens johnson syndrome , Stevens johnson syndrome , Thrombocytopenia , Aplastic anemia , Leucopenia, Crystalluria , Methemoglobinemia, Aplastic anemia, Hemolytic anemia , Agranulocytosis , Interstitial nephritis , Acute renal failure , Methemoglobinemia .
Co-Trimoxazole is known to cause more or less tolerable side effects which are usually transient. These include Exfoliative dermatitis, GI symptoms, Nausea, Skin rashes, Skin reactions, Vomiting .
Warnings / Precautions
Interference in Pathology
Co-Trimoxazole may interfere in the diagnosis of Overstimation of serum creatinine with alkaline picrate reaction. .
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.6.2.2.8 — Sulphonamides and trimethoprim